市場調查報告書

目錄肽市場調查報告:種類,用途,終端用戶,地理展望-全世界的產業規模,佔有率分析,至2024年的成長預測

Catalog Peptides Market Research Report: By Type, Application, End-User, Geographical Outlook - Global Industry Size, Share Analysis and Growth Forecast to 2024

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 918857
出版日期 內容資訊 英文 346 Pages
商品交期: 2-3個工作天內
價格
Back to Top
目錄肽市場調查報告:種類,用途,終端用戶,地理展望-全世界的產業規模,佔有率分析,至2024年的成長預測 Catalog Peptides Market Research Report: By Type, Application, End-User, Geographical Outlook - Global Industry Size, Share Analysis and Growth Forecast to 2024
出版日期: 2019年08月01日內容資訊: 英文 346 Pages
簡介

全球目錄肽市場在2018年估算為2億3,840萬美元的規模。該市場在2019年∼2024年間,預測將以5.8%的年複合成長率成長,2024年成長到3億3,210萬美元。為了開發蛋白質為基礎的研究,技術進步,慢性病患的負擔增加,創新的治療方法的研究活動增加的資金增加等,是該市場成長的主要推動因素。

本報告提供全球目錄肽市場的相關調查,市場機會和趨勢,成長及阻礙因素,各類型、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 背景調查

  • 調查目的
  • 市場定義
  • 調查範圍
    • 各類型
    • 各用途
    • 各終端用戶
    • 各地區
    • 分析期間
    • 市場資料報告的單位
  • 主要的利害關係者

第2章 調查方法

  • 二次調查
  • 一次調查
    • 主要的調查受訪者的明細
  • 市場規模的估計
  • 資料三角測量
  • 調查的前提條件

第3章 摘要整理

第4章 簡介

  • 市場區隔定義
    • 各類型
    • 各用途
    • 各終端用戶
  • 市場動態
    • 市場趨勢
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
  • 目錄肽的法規方案
    • 北美
    • 歐洲
  • 目錄肽的優點

第5章 全球市場規模及預測

  • 各類型
  • 各用途
    • 商業用:各類型
    • 學術研究用:各類型
  • 各終端用戶
  • 各地區

第6章 北美

  • 各國
    • 美國
    • 加拿大

第7章 歐洲

  • 各國
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區

  • 各國
    • 中國
    • 日本
    • 印度
    • 韓國
    • 新加坡

第9章 南美

  • 各國
    • 巴西
    • 墨西哥

第10章 中東、非洲

  • 各國
    • 以色列
    • 南非
    • 沙烏地阿拉伯

第11章 競爭情形

  • 主要企業及提供產品
  • 主要企業的排行榜
  • 主要企業的策略性開發
    • 產品的銷售
    • 收購
    • 設施擴張
    • 其他開發

第12章 企業簡介

  • PolyPeptide Group
  • CSBio
  • GL Biochem (Shanghai) Ltd.
  • CPC Scientific Inc.
  • Auspep Pty Ltd.
  • Peptides International Inc.
  • Applied Biological Materials (ABM) Inc.
  • Biomatik Corporation
  • Bio-Synthesis Inc.
  • Thermo Fisher Scientific Inc.
  • GenScript Biotech Corporation
  • Bachem AG
  • JPT Peptide Technologies GmbH
  • Advanced ChemTech
  • LifeTein LLC
  • Kaneka Eurogentec S.A.(Kaneka Corporation)
  • Elim Biopharm Inc.
  • Creative Peptides
  • Abbiotec Inc.
  • NovoPro Bioscience Inc.
  • KareBay Biochem Inc.
  • Ontores Biotechnologies Inc.
  • Severn Biotech Ltd.
  • Genway Biotech Inc.
  • Kaneka Corporation
  • New England Peptide Inc.
  • AnaSpec Inc.
  • AAPPTec LLC
  • Merck KGaA

第13章 附錄

  • 簡稱
  • 資訊來源、 索引
  • 相關報告
目錄

The catalog peptides market is expected to grow to $332.1 million by 2024 at a CAGR of 5.8% during the forecast period (2019-2024), from $238.4 million in 2018. The increasing funding in protein-based research, technical advancements, rising chronic disease burden, and growing research activities to develop innovative therapies are the major drivers of the market. A short chain of amino acids, in which the amino acids are linked together by peptide bonds, constitutes a peptide. Catalog peptides are off-the-shelf products, which are available with manufacturers for use in biochemistry, molecular medicine, and pharmacology.

The catalog peptides market is observing growth due to advancements in technology that help in the cost-effective manufacturing of peptides. Previously, peptides were synthesized from natural sources, such as adrenocorticotropic hormone (ACTH) derived from the porcine or bovine pituitary and insulin from bovine or canine pancreas. The production of naturally synthesized peptides is not only time consuming, but also has low yield and is much more cost-intensive. With technical advancements, peptides, such as octreotide, oxytocin, leuprorelin, and vasopressin, can be synthesized using solid-phase synthesis.

The subdivisions of the catalog peptides market, based on type, are G protein-coupled receptor (GPCR), calcitonin gene-related, anti-microbial, caspase-related, tau, amyloid, amylin, adrenomedullin, and cyclic. Cyclic proteins contributed about 11.3% of the total revenue to the market in 2018. These peptides have diverse biological activities, such as immunosuppressive, antibacterial, and anti-tumor activities, which contributed in their significant market share. Owing to their wide-ranging application, cyclic peptides are predicted to be the leader in revenue generation during the forecast period too.

Asia-Pacific (APAC) can be the most lucrative region for the catalog peptides market to maximize revenue. A 2017 United Nations factsheet mentioned that the population above the age of 60 would double by 2050 across the globe. With the rising prevalence of chronic diseases, the demand for novel therapies is increasing for the proper management of such diseases. As the APAC region accounts for 60.0% of the world's population, the demand for catalog peptides is expected to be high here. Further, low manufacturing costs and lenient regulations are inviting foreign investments.

Hence, the market for catalog peptides is slated to advance in the forecast period due to the rising chronic disease prevalence, increasing research activities, and technical advancements.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Type
    • 1.3.2 Market Segmentation by Application
    • 1.3.3 Market Segmentation by End User
    • 1.3.4 Market Segmentation by Geography
    • 1.3.5 Analysis Period
    • 1.3.6 Market Data Reporting Unit
      • 1.3.6.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Type
      • 4.1.1.1 Cyclic
      • 4.1.1.2 Calcitonin gene-related
      • 4.1.1.3 Caspase related
      • 4.1.1.4 Amyloid
      • 4.1.1.5 Adrenomedullin
      • 4.1.1.6 Amylin
      • 4.1.1.7 Tau
      • 4.1.1.8 Cosmetic
      • 4.1.1.9 Anti-microbial
      • 4.1.1.10 GPCR
      • 4.1.1.11 Others
    • 4.1.2 By Application
      • 4.1.2.1 Commercial
        • 4.1.2.1.1 Antibody production
        • 4.1.2.1.2 Drug discovery
        • 4.1.2.1.3 Enzyme profiling
        • 4.1.2.1.4 Others
      • 4.1.2.2 Academic research
        • 4.1.2.2.1 Disease research
          • 4.1.2.2.1.1 Cancer and apoptosis
          • 4.1.2.2.1.2 Cardiovascular
          • 4.1.2.2.1.3 Diabetes
          • 4.1.2.2.1.4 Neuroscience
          • 4.1.2.2.1.5 Infectious diseases
          • 4.1.2.2.1.6 Anti-inflammatory
          • 4.1.2.2.1.7 Blood disorders
          • 4.1.2.2.1.8 Others
        • 4.1.2.2.2 Biomarker discovery
        • 4.1.2.2.3 Others
      • 4.1.2.3 Therapeutics
    • 4.1.3 By End User
      • 4.1.3.1 Pharmaceutical and biotechnology companies
      • 4.1.3.2 CMOs and CROs
      • 4.1.3.3 Academic and research institutes
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Evolution of the market with product and service launches
      • 4.2.1.2 Increasing research activities related to recombinant proteins
    • 4.2.2 Drivers
      • 4.2.2.1 Development of technologies for cost-effective manufacturing
      • 4.2.2.2 Increasing research activities to address unmet medical needs in various therapeutic areas
      • 4.2.2.3 Growing burden of chronic diseases
      • 4.2.2.4 Increasing investments and funding for protein-based research
      • 4.2.2.5 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Lack of updation in regulatory standards
      • 4.2.3.2 Contamination issues during peptide synthesis and high capital requirements for drug development
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Emerging markets in the APAC region
      • 4.2.4.2 Rising number of approvals for peptide-based drugs
    • 4.2.5 Challenges
      • 4.2.5.1 Low bioavailability and short half-life of peptides
      • 4.2.5.2 High cost of synthetic peptides
  • 4.3 Porter's Five Forces Analysis
  • 4.4 Regulatory Scenario for Catalog Peptides
    • 4.4.1 North America
    • 4.4.2 Europe
  • 4.5 Benefits of Catalog Peptides

Chapter 5. Global Market Size and Forecast

  • 5.1 By Type
  • 5.2 By Application
    • 5.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 5.2.2 Catalog Peptides Market for Academic Research, by Type
    • 5.2.2.1 Catalog peptides market for disease research, by type
  • 5.3 By End User
  • 5.4 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Type
  • 6.2 By Application
    • 6.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 6.2.2 Catalog Peptides Market for Academic Research, by Type
      • 6.2.2.1 Catalog peptides market for disease research, by type
  • 6.3 By End User
  • 6.4 By Country
    • 6.4.1 U.S. Market Size and Forecast
      • 6.4.1.1 By type
      • 6.4.1.2 By application
        • 6.4.1.2.1 Catalog peptides market for commercial application, by type
        • 6.4.1.2.2 Catalog peptides market for academic research, by type
          • 6.4.1.2.2.1 Catalog peptides market for disease research, by type
        • 6.4.1.3 By end user
    • 6.4.2 Canada Market Size and Forecast
      • 6.4.2.1 By type
      • 6.4.2.2 By application
        • 6.4.2.2.1 Catalog peptides market for commercial application, by type
        • 6.4.2.2.2 Catalog peptides market for academic research, by type
          • 6.4.2.2.2.1 Catalog peptides market for disease research, by type
      • 6.4.2.3 By end user

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Type
  • 7.2 By Application
    • 7.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 7.2.2 Catalog Peptides Market for Academic Research, by Type
      • 7.2.2.1 Catalog peptides market for disease research, by type
  • 7.3 By End User
  • 7.4 By Country
    • 7.4.1 Germany Market Size and Forecast
      • 7.4.1.1 By type
      • 7.4.1.2 By application
        • 7.4.1.2.1 Catalog peptides market for commercial application, by type
        • 7.4.1.2.2 Catalog peptides market for academic research, by type
          • 7.4.1.2.2.1 Catalog peptides market for disease research, by type
      • 7.4.1.3 By end user
    • 7.4.2 France Market Size and Forecast
      • 7.4.2.1 By type
      • 7.4.2.2 By application
        • 7.4.2.2.1 Catalog peptides market for commercial application, by type
        • 7.4.2.2.2 Catalog peptides market for academic research, by type
          • 7.4.2.2.2.1 Catalog peptides market for disease research, by type
      • 7.4.2.3 By end user
    • 7.4.3 U.K. Market Size and Forecast
      • 7.4.3.1 By type
      • 7.4.3.2 By application
        • 7.4.3.2.1 Catalog peptides market for commercial application, by type
        • 7.4.3.2.2 Catalog peptides market for academic research, by type
          • 7.4.3.2.2.1 Catalog peptides market for disease research, by type
      • 7.4.3.3 By end user
    • 7.4.4 Italy Market Size and Forecast
      • 7.4.4.1 By type
      • 7.4.4.2 By application
        • 7.4.4.2.1 Catalog peptides market for commercial application, by type
        • 7.4.4.2.2 Catalog peptides market for academic research, by type
          • 7.4.4.2.2.1 Catalog peptides market for disease research, by type
      • 7.4.4.3 By end user
    • 7.4.5 Spain Market Size and Forecast
      • 7.4.5.1 By type
      • 7.4.5.2 By application
        • 7.4.5.2.1 Catalog peptides market for commercial application, by type
        • 7.4.5.2.2 Catalog peptides market for academic research, by type
          • 7.4.5.2.2.1 Catalog peptides market for disease research, by type
      • 7.4.5.3 By end user

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Type
  • 8.2 By Application
    • 8.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 8.2.2 Catalog Peptides Market for Academic Research, by Type
      • 8.2.2.1 Catalog peptides market for disease research, by type
  • 8.3 By End User
  • 8.4 By Country
    • 8.4.1 China Market Size and Forecast
      • 8.4.1.1 By type
      • 8.4.1.2 By application
        • 8.4.1.2.1 Catalog peptides market for commercial application, by type
        • 8.4.1.2.2 Catalog peptides market for academic research, by type
          • 8.4.1.2.2.1 Catalog peptides market for disease research, by type
      • 8.4.1.3 By end user
    • 8.4.2 Japan Market Size and Forecast
      • 8.4.2.1 By type
      • 8.4.2.2 By application
        • 8.4.2.2.1 Catalog peptides market for commercial application, by type
        • 8.4.2.2.2 Catalog peptides market for academic research, by type
          • 8.4.2.2.2.1 Catalog peptides market for disease research, by type
      • 8.4.2.3 By end user
    • 8.4.3 India Market Size and Forecast
      • 8.4.3.1 By type
      • 8.4.3.2 By application
        • 8.4.3.2.1 Catalog peptides market for commercial application, by type
        • 8.4.3.2.2 Catalog peptides market for academic research, by type
          • 8.4.3.2.2.1 Catalog peptides market for disease research, by type
      • 8.4.3.3 By end user
    • 8.4.4 South Korea Market Size and Forecast
      • 8.4.4.1 By type
      • 8.4.4.2 By application
        • 8.4.4.2.1 Catalog peptides market for commercial application, by type
        • 8.4.4.2.2 Catalog peptides market for academic research, by type
          • 8.4.4.2.2.1 Catalog peptides market for disease research, by type
      • 8.4.4.3 By end user
    • 8.4.5 Singapore Market Size and Forecast
      • 8.4.5.1 By type
      • 8.4.5.2 By application
        • 8.4.5.2.1 Catalog peptides market for commercial application, by type
        • 8.4.5.2.2 Catalog peptides market for academic research, by type
          • 8.4.5.2.2.1 Catalog peptides market for disease research, by type
      • 8.4.5.3 By end user

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Type
  • 9.2 By Application
    • 9.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 9.2.2 Catalog Peptides Market for Academic Research, by Type
      • 9.2.2.1 Catalog peptides market for disease research, by type
  • 9.3 By End User
  • 9.4 By Country
    • 9.4.1 Brazil Market Size and Forecast
      • 9.4.1.1 By type
      • 9.4.1.2 By application
        • 9.4.1.2.1 Catalog peptides market for commercial application, by type
        • 9.4.1.2.2 Catalog peptides market for academic research, by type
          • 9.4.1.2.2.1 Catalog peptides market for disease research, by type
      • 9.4.1.3 By end user
    • 9.4.2 Mexico Market Size and Forecast
      • 9.4.2.1 By type
      • 9.4.2.2 By application
        • 9.4.2.2.1 Catalog peptides market for commercial application, by type
        • 9.4.2.2.2 Catalog peptides market for academic research, by type
          • 9.4.2.2.2.1 Catalog peptides market for disease research, by type
      • 9.4.2.3 By end user

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Type
  • 10.2 By Application
    • 10.2.1 Catalog Peptides Market for Commercial Application, by Type
    • 10.2.2 Catalog Peptides Market for Academic Research, by Type
      • 10.2.2.1 Catalog peptides market for disease research, by type
  • 10.3 By End User
  • 10.4 By Country
    • 10.4.1 Israel Market Size and Forecast
      • 10.4.1.1 By type
      • 10.4.1.2 By application
        • 10.4.1.2.1 Catalog peptides market for commercial application, by type
        • 10.4.1.2.2 Catalog peptides market for academic research, by type
          • 10.4.1.2.2.1 Catalog peptides market for disease research, by type
      • 10.4.1.3 By end user
    • 10.4.2 South Africa Market Size and Forecast
      • 10.4.2.1 By type
      • 10.4.2.2 By application
        • 10.4.2.2.1 Catalog peptides market for commercial application, by type
        • 10.4.2.2.2 Catalog peptides market for academic research, by type
          • 10.4.2.2.2.1 Catalog peptides market for disease research, by type
      • 10.4.2.3 By end user
    • 10.4.3 Saudi Arabia Market Size and Forecast
      • 10.4.3.1 By type
      • 10.4.3.2 By application
        • 10.4.3.2.1 Catalog peptides market for commercial application, by type
        • 10.4.3.2.2 Catalog peptides market for academic research, by type
          • 10.4.3.2.2.1 Catalog peptides market for disease research, by type
      • 10.4.3.3 By end user

Chapter 11. Competitive Landscape

  • 11.1 Key Players and their Product Offerings
  • 11.2 Ranking of the Key Players
  • 11.3 Strategic Developments of the Key Players
    • 11.3.1 Product Launches
    • 11.3.2 Acquisitions
    • 11.3.3 Facility Expansions
    • 11.3.4 Other Developments

Chapter 12. Company Profiles

  • 12.1 PolyPeptide Group
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
  • 12.2 CSBio
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 GL Biochem (Shanghai) Ltd.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
  • 12.4 CPC Scientific Inc.
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
  • 12.5 Auspep Pty Ltd.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Peptides International Inc.
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
  • 12.7 Applied Biological Materials (ABM) Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
  • 12.8 Biomatik Corporation
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
  • 12.9 Bio-Synthesis Inc.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
  • 12.10 Thermo Fisher Scientific Inc.
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
    • 12.10.3 Key Financial Summary
  • 12.11 GenScript Biotech Corporation
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 Bachem AG
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 JPT Peptide Technologies GmbH
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 Advanced ChemTech
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
  • 12.15 LifeTein LLC
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
  • 12.16 Kaneka Eurogentec S.A.
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
  • 12.17 Elim Biopharm Inc.
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
  • 12.18 Creative Peptides
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
  • 12.19 Abbiotec Inc.
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings
  • 12.20 NovoPro Bioscience Inc.
    • 12.20.1 Business Overview
    • 12.20.2 Product and Service Offerings
  • 12.21 KareBay Biochem Inc.
    • 12.21.1 Business Overview
    • 12.21.2 Product and Service Offerings
  • 12.22 Ontores Biotechnologies Inc.
    • 12.22.1 Business Overview
    • 12.22.2 Product and Service Offerings
  • 12.23 Severn Biotech Ltd.
    • 12.23.1 Business Overview
    • 12.23.2 Product and Service Offerings
  • 12.24 Genway Biotech Inc.
    • 12.24.1 Business Overview
    • 12.24.2 Product and Service Offerings
  • 12.25 Kaneka Corporation
    • 12.25.1 Business Overview
    • 12.25.2 Product and Service Offerings
    • 12.25.3 Key Financial Summary
  • 12.26 New England Peptide Inc.
    • 12.26.1 Business Overview
    • 12.26.2 Product and Service Offerings
  • 12.27 AnaSpec Inc.
    • 12.27.1 Business Overview
    • 12.27.2 Product and Service Offerings
  • 12.28 AAPPTec LLC
    • 12.28.1 Business Overview
    • 12.28.2 Product and Service Offerings
  • 12.29 Merck KGaA
    • 12.29.1 Business Overview
    • 12.29.2 Product and Service Offerings
    • 12.29.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

List of Tables

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 NUMBER OF DEATHS DUE TO VARIOUS DISEASES WORLDWIDE
  • TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 5 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 6 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 7 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 8 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 9 GLOBAL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 10 GLOBAL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 11 GLOBAL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 12 GLOBAL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 13 GLOBAL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 14 GLOBAL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 15 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 16 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 17 GLOBAL CATALOG PEPTIDES MARKET, BY REGION, $'000 (2014-2018)
  • TABLE 18 GLOBAL CATALOG PEPTIDES MARKET, BY REGION, $'000 (2019-2024)
  • TABLE 19 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 20 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 21 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 22 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 23 NORTH AMERICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 24 NORTH AMERICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 25 NORTH AMERICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 26 NORTH AMERICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 27 NORTH AMERICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 28 NORTH AMERICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 29 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 30 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 31 NORTH AMERICA CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2018)
  • TABLE 32 NORTH AMERICA CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2019-2024)
  • TABLE 33 U.S. CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 34 U.S. CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 35 U.S. CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 36 U.S. CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 37 U.S. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 38 U.S. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 39 U.S. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 40 U.S. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 41 U.S. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 42 U.S. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 43 U.S. CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 44 U.S. CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 45 CANADA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 46 CANADA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 47 CANADA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 48 CANADA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 49 CANADA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 50 CANADA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 51 CANADA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 52 CANADA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 53 CANADA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 54 CANADA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 55 CANADA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 56 CANADA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 57 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 58 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 59 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 60 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 61 EUROPE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 62 EUROPE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 63 EUROPE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 64 EUROPE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 65 EUROPE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 66 EUROPE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 67 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 68 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 69 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2018)
  • TABLE 70 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2019-2024)
  • TABLE 71 GERMANY CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 72 GERMANY CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 73 GERMANY CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 74 GERMANY CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 75 GERMANY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 76 GERMANY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 77 GERMANY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 78 GERMANY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 79 GERMANY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 80 GERMANY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 81 GERMANY CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 82 GERMANY CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 83 FRANCE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 84 FRANCE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 85 FRANCE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 86 FRANCE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 87 FRANCE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 88 FRANCE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 89 FRANCE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 90 FRANCE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 91 FRANCE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 92 FRANCE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 93 FRANCE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 94 FRANCE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 95 U.K. CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 96 U.K. CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 97 U.K. CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 98 U.K. CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 99 U.K. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 100 U.K. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 101 U.K. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 102 U.K. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 103 U.K. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 104 U.K. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 105 U.K. CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 106 U.K. CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 107 ITALY CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 108 ITALY CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 109 ITALY CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 110 ITALY CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 111 ITALY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 112 ITALY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 113 ITALY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 114 ITALY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 115 ITALY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 116 ITALY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 117 ITALY CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 118 ITALY CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 119 SPAIN CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 120 SPAIN CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 121 SPAIN CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 122 SPAIN CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 123 SPAIN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 124 SPAIN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 125 SPAIN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 126 SPAIN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 127 SPAIN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 128 SPAIN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 129 SPAIN CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 130 SPAIN CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 131 APAC CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 132 APAC CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 133 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 134 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 135 APAC CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 136 APAC CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 137 APAC CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 138 APAC CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 139 APAC CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 140 APAC CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 141 APAC CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 142 APAC CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 143 APAC CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2018)
  • TABLE 144 APAC CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2019-2024)
  • TABLE 145 CHINA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 146 CHINA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 147 CHINA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 148 CHINA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 149 CHINA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 150 CHINA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 151 CHINA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 152 CHINA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 153 CHINA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 154 CHINA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 155 CHINA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 156 CHINA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 157 JAPAN CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 158 JAPAN CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 159 JAPAN CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 160 JAPAN CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 161 JAPAN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 162 JAPAN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 163 JAPAN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 164 JAPAN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 165 JAPAN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 166 JAPAN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 167 JAPAN CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 168 JAPAN CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 169 INDIA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 170 INDIA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 171 INDIA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 172 INDIA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 173 INDIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 174 INDIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 175 INDIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 176 INDIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 177 INDIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 178 INDIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 179 INDIA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 180 INDIA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 181 SOUTH KOREA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 182 SOUTH KOREA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 183 SOUTH KOREA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 184 SOUTH KOREA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 185 SOUTH KOREA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 186 SOUTH KOREA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 187 SOUTH KOREA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 188 SOUTH KOREA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $000 (2019-2024)
  • TABLE 189 SOUTH KOREA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 190 SOUTH KOREA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 191 SOUTH KOREA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 192 SOUTH KOREA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 193 SINGAPORE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 194 SINGAPORE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 195 SINGAPORE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 196 SINGAPORE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 197 SINGAPORE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 198 SINGAPORE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 199 SINGAPORE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 200 SINGAPORE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 201 SINGAPORE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 202 SINGAPORE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 203 SINGAPORE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 204 SINGAPORE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 205 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 206 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 207 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 208 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 209 LATAM CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 210 LATAM CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 211 LATAM CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 212 LATAM CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 213 LATAM CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 214 LATAM CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 215 LATAM CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 216 LATAM CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 217 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2018)
  • TABLE 218 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2019-2024)
  • TABLE 219 BRAZIL CATALOG PEPTIDES MARKET, BY TYPE, $$'000 (2014-2018)
  • TABLE 220 BRAZIL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 221 BRAZIL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 222 BRAZIL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 223 BRAZIL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 224 BRAZIL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 225 BRAZIL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 226 BRAZIL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 227 BRAZIL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 228 BRAZIL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 229 BRAZIL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 230 BRAZIL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 231 MEXICO CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 232 MEXICO CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 233 MEXICO CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 234 MEXICO CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 235 MEXICO CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 236 MEXICO CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 237 MEXICO CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 238 MEXICO CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 239 MEXICO CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 240 MEXICO CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 241 MEXICO CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 242 MEXICO CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 243 MEA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 244 MEA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 245 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 246 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 247 MEA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 248 MEA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 249 MEA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 250 MEA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 251 MEA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 252 MEA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 253 MEA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 254 MEA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 255 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2018)
  • TABLE 256 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2019-2024)
  • TABLE 257 ISRAEL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 258 ISRAEL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 259 ISRAEL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 260 ISRAEL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 261 ISRAEL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 262 ISRAEL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 263 ISRAEL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 264 ISRAEL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 265 ISRAEL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 266 ISRAEL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 267 ISRAEL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 268 ISRAEL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 269 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 270 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 271 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 272 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 273 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 274 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 275 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 276 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 277 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 278 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 279 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 280 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 281 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2018)
  • TABLE 282 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2019-2024)
  • TABLE 283 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2018)
  • TABLE 284 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2019-2024)
  • TABLE 285 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2014-2018)
  • TABLE 286 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $'000 (2019-2024)
  • TABLE 287 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 288 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 289 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2014-2018)
  • TABLE 290 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $'000 (2019-2024)
  • TABLE 291 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2018)
  • TABLE 292 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2019-2024)
  • TABLE 293 POLYPEPTIDE GROUP - AT A GLANCE
  • TABLE 294 CSBIO - AT A GLANCE
  • TABLE 295 GL BIOCHEM (SHANGHAI) LTD. - AT A GLANCE
  • TABLE 296 CPC SCIENTIFIC INC. - AT A GLANCE
  • TABLE 297 AUSPEP PTY LTD. - AT A GLANCE
  • TABLE 298 PEPTIDES INTERNATIONAL INC. - AT A GLANCE
  • TABLE 299 APPLIED BIOLOGICAL MATERIALS (ABM) INC. - AT A GLANCE
  • TABLE 300 BIOMATIK CORPORATION - AT A GLANCE
  • TABLE 301 BIO-SYNTHESIS INC. - AT A GLANCE
  • TABLE 302 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 303 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 304 GENSCRIPT BIOTECH CORPORATION - AT A GLANCE
  • TABLE 305 GENSCRIPT BIOTECH CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 306 BACHEM AG - AT A GLANCE
  • TABLE 307 BACHEM AG - KEY FINANCIAL SUMMARY
  • TABLE 308 JPT PEPTIDE TECHNOLOGIES GMBH - AT A GLANCE
  • TABLE 309 ADVANCED CHEMTECH - AT A GLANCE
  • TABLE 310 LIFETEIN LLC - AT A GLANCE
  • TABLE 311 KANEKA EUROGENTEC S.A. - AT A GLANCE
  • TABLE 312 ELIM BIOPHARM INC. - AT A GLANCE
  • TABLE 313 CREATIVE PEPTIDES - AT A GLANCE
  • TABLE 314 ABBIOTEC INC. - AT A GLANCE
  • TABLE 315 NOVOPRO BIOSCIENCE INC. - AT A GLANCE
  • TABLE 316 KAREBAY BIOCHEM INC. - AT A GLANCE
  • TABLE 317 ONTORES BIOTECHNOLOGIES INC. - AT A GLANCE
  • TABLE 318 SEVERN BIOTECH LTD. - AT A GLANCE
  • TABLE 319 GENWAY BIOTECH INC. - AT A GLANCE
  • TABLE 320 KANEKA CORPORATION - AT A GLANCE
  • TABLE 321 KANEKA CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 322 NEW ENGLAND PEPTIDE INC. - AT A GLANCE
  • TABLE 323 ANASPEC INC. - AT A GLANCE
  • TABLE 324 AAPPTECH LLC - AT A GLANCE
  • TABLE 325 MERCK KGAA - AT A GLANCE
  • TABLE 326 MERCK KGAA - KEY FINANCIAL SUMMARY

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL CATALOG PEPTIDES MARKET SUMMARY
  • FIG 9 BARGAINING POWER OF BUYERS
  • FIG 10 BARGAINING POWER OF SUPPLIERS
  • FIG 11 INTENSITY OF RIVALRY
  • FIG 12 THREAT OF NEW ENTRANTS
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 SNAPSHOT OF GLOBAL CATALOG PEPTIDES MARKET
  • FIG 15 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 16 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 17 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 18 WORLDWIDE MAJOR MARKETS FOR CATALOG PEPTIDES
  • FIG 19 NORTH AMERICA CATALOG PEPTIDES MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 21 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 22 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 23 NORTH AMERICA CATALOG PAPTIDES MARKET, BY COUNTRY, $'000 (2014-2024)
  • FIG 24 EUROPE CATALOG PEPTIDES MARKET SNAPSHOT
  • FIG 25 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 26 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 27 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 28 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2024)
  • FIG 29 APAC CATALOG PEPTIDES MARKET SNAPSHOT
  • FIG 30 APAC CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 31 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 32 APAC CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 33 APAC CATALOG PAPETIDES MARKET, BY COUNTRY, $'000 (2014-2024)
  • FIG 34 LATAM CATALOG PEPTIDES MARKET SNAPSHOT
  • FIG 35 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 36 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 37 LATAM CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 38 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2024)
  • FIG 39 MEA CATALOG PEPTIDES MARKET SNAPSHOT
  • FIG 40 MEA CATALOG PEPTIDES MARKET, BY TYPE, $'000 (2014-2024)
  • FIG 41 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $'000 (2014-2024)
  • FIG 42 MEA CATALOG PEPTIDES MARKET, BY END USER, $'000 (2014-2024)
  • FIG 43 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $'000 (2014-2024)
  • FIG 44 KEY PLAYERS OFFERINGS
  • FIG 45 RANKING OF THE KEY PLAYERS
  • FIG 46 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 47 GENESCRIPT BIOTECH CORPORATION - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2017)
  • FIG 48 BACHEM AG - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2018)
  • FIG 49 MERCK KGAA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
Back to Top